Patent details

EP3641769 Title: 1-[(2,3,4-TRIMETHOXYPHENYL)METHYL]-PIPERAZINE DERIVATIVE, COMPOSITIONS THEREOF AND METHODS FOR INCREASING EFFICIENCY OF CARDIAC METABOLISM

Basic Information

Publication number:
EP3641769
PCT Application Number:
US2018038067
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP188215909
PCT Publication Number:
WO2018236745
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
1-[(2,3,4-TRIMETHOXYPHENYL)METHYL]-PIPERAZINE DERIVATIVE, COMPOSITIONS THEREOF AND METHODS FOR INCREASING EFFICIENCY OF CARDIAC METABOLISM
French Title of Invention:
DÉRIVÉ DE 1-[(2,3,4-TRIMÉTHOXYPHÉNYL)MÉTHYL]-PIPERAZINE, SES COMPOSITIONS ET PROCÉDÉS POUR AUGMENTER L'EFFICACITÉ DU MÉTABOLISME CARDIAQUE
German Title of Invention:
1-[(2,3,4-TRIMETHOXYPHENYL)METHYL]-PIPERAZIN-DERIVAT, DESSEN ZUSAMMENSETZUNGEN UND VERFAHREN ZUR ERHÖHUNG DER EFFIZIENZ DES HERZMETABOLISMUS
SPC Number:

Dates

Filing date:
18/06/2018
Grant date:
08/06/2022
EP Publication Date:
29/04/2020
PCT Publication Date:
27/12/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/06/2022
EP B1 Publication Date:
08/06/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/06/2022
Expiration date:
18/06/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/08/2022
 
 

Name:
Imbria Pharmaceuticals, Inc.
Address:
265 Franklin Street, Suite 1702, Boston, MA 02110, United States (US)

History of Owners

From:
01/06/2022
To:
05/08/2022

Name:
Imbria Pharmaceuticals, Inc.
Address:
12770 High Bluff Drive, Suite 270, San Diego, CA 92130, United States (US)

Inventor

Name:
LEVIN, Andrew
Address:
United States (US)

Priority

1

Priority Number:
201762522214 P
Priority Date:
20/06/2017
Priority Country:
United States (US)

2

Priority Number:
201762524237 P
Priority Date:
23/06/2017
Priority Country:
United States (US)

3

Priority Number:
201862710316 P
Priority Date:
16/02/2018
Priority Country:
United States (US)

4

Priority Number:
201862637434 P
Priority Date:
02/03/2018
Priority Country:
United States (US)

5

Priority Number:
201862647926 P
Priority Date:
26/03/2018
Priority Country:
United States (US)

Classification

IPC classification:
C07D 213/80; A61K 31/455; A61K 31/495; A61K 31/55; A61P 3/00; A61P 9/00; A61P 21/00;

Publication

European Patent Bulletin

1

Issue number:
202223
Publication date:
08/06/2022
Description:
Grant (B1)

2

Issue number:
202236
Publication date:
07/09/2022
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages